C.HirschE
Hansoh is currently running both a phase 2b study of the drug in diabetes and a phase 3 trial in obesity in its home territory of China
Arecoline hydrobromide suppresses PI3K/AKT pathway in rheumatoid arthritis synovial fibroblasts and relieves collagen-induced arthritis in mice
Study identifies gut-brain-immune network influencing effectiveness of GLP-1 agonists owenhaskins Dec 19, 2023 3 min read Researchers at the Lunenfeld-Tanenbaum Research Institute, part of Sinai Health, have discovered a gut-brain-immune network and posit a new gut-brain glucagon-like peptide 1 (GLP-1R) that controls inflammation across the body, a discovery which holds promise for understanding and treating metabolic diseases
By promoting satiety, preserving lean muscle mass, supporting blood sugar regulation, and boosting metabolism, protein-rich foods can help you achieve better health outcomes
In a second group of subjects, a d 9 -BB challenge was performed with 250 mg d 9 - BB